Hologic wins key Siemens patent fight as breast imaging market enters sharper phase
Find out how Hologic’s patent victory against Siemens Healthineers could reshape breast cancer detection technology and medtech competition.
Medical Devices & Diagnostics
Pharma & Biotech
Angelini Pharma bets $4.1bn on rare neurology scale with Catalyst Pharmaceuticals
Angelini gains U.S. rare disease scale. Catalyst gets certainty, but Firdapse concentration keeps the real test ahead.